Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 17, 2026 | BlueCross BlueShield of Tennessee | Cosibelimab-ipdl (Unloxcyt) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Secukinumab (Cosentyx) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Trilaciclib (Cosela) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Surgical Ventricular Restoration | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Continuous Passive Motion Cpm Device | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Continuous Home Pulse Oximetry | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Confocal Laser Endomicroscopy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Computerized 2-lead Resting Electrocardiogram Analysis for the Diagnosis of Coronary Artery Disease | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Computer Assisted Surgical Navigation for Orthopedic Procedures | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Coronary Computed Tomography Angiography (CCTA) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Hand and/or Face Transplantation (Composite Tissue Allotransplantation) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Glofitamab-gxbm (Columvi) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Collagenase Clostridium Histolyticum (Xiaflex) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Corneal Collagen Cross-Linking | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Intervertebral Disc Decompression using Radiofrequency Coblation (Nucleoplasty) or Laser Energy (Laser Discectomy) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Circulating Tumor DNA (Liquid Biopsy) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Cipaglucosidase Alfa-atga (Pombiliti) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Reslizumab (Cinqair) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Dynamic Spinal Visualization and Vertebral Motion Analysis | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Chronic Intermittent Intravenous Insulin Therapy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Chromosomal Microarray Analysis for Evaluation of Pregnancy Loss | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Mentoplasty (Chin Augmentation, Genioplasty) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Transcatheter Hepatic Arterial Chemoembolization | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Chelation Therapy | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Genetic Testing for CHEK2 Mutations for Breast Cancer | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Genetic Testing for CHARGE Syndrome | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Cetuximab (Erbitux) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Cervical Traction Devices for Home Use | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Certolizumab Pegol (Cimzia) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Imiglucerase (Cerezyme) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Hematopoietic Stem Cell Transplantation for Central Nervous System Embryonal and Ependymoma Tumors | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Cemiplimab-rwlc (Libtayo) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Exagamglogene Autotemcel (Casgevy) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Ciltacabtagene Autoleucel (Carvykti) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Ultrasonographic Measurements of Carotid Intima-Medial Thickness (CIMT) as an Assessment of Subclinical Atherosclerosis | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Intravenous Immune Globulin (IVIG) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Carfilzomib (Kyprolis) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Wearable Cardioverter Defibrillator | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Canakinumab (Ilaris) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Cabazitaxel (Jevtana) Cabazitaxel | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | C1 Esterase Inhibitor Subcutaneous (Human) - Haegarda | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | C1 Esterase Inhibitor (recombinant) - Ruconest | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | C1 Esterase Inhibitor (Human) - Cinryze | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Burosumab-twza(Crysvita) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Bulking Agents for the Treatment of Vesicoureteral Reflux (VUR) and Incontinence | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Browplasty | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Oscillating Devices for the Treatment of Respiratory Conditions | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Cerliponase Alfa(Brineura) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Lisocabtagene Maraleucel (Breyanzi) | Criteria changed |
| May 17, 2026 | BlueCross BlueShield of Tennessee | Brexucabtagene Autoleucel (Tecartus) | Criteria changed |